Precision Therapeutics, Inc. Signs Letter of Intent to Purchase Remainder of Helomics Corporation Shares

    NEXT STORY
    AzurRx BioPharma and Mayoly-Spindler Announce Additional Positive Interim Data for MS1819-SD Phase II in Exocrine Pancreatic Insufficiency (EPI)
    PREV STORY
    Achaogen Highlights Plazomicin Presentations at European Congress of Clinical Microbiology and Infectious Diseases (ECCMID)
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Athenex Announces Late-Breaking Oral Presentation of KX2-391 Ointment in Two Phase III Studies at the American Academy of Dermatology Annual Meeting

    Results from Phase III pivotal studies to be featured at Late-Breaking Research Program on ...

    author_avatar
    NASDAQ Market News

    Global Syringe & Needle Industry Assessment 2020-2025: COVID-19 Updated

    author_avatar
    NASDAQ Market News

    Sera Prognostics Partners With Anthem and HealthCore to Improve Outcomes for Preterm Babies

    author_avatar
    NASDAQ Market News